Differentially expressed genes SNRPC and PRPF38A are potential biomarkers candidates for osteosarcoma

Abstract

Background: Osteosarcoma (osteogenic sarcoma, OS) is a primary cause of morbidity and mortality and is associated with poor prognosis in the field of orthopedic. Globally, rates of OS are highest among 15 to 25-year-old adolescent. However, the mechanism of gene regulation and signaling pathway is unknown. Material and Methods: GSE9508, including 34 OS samples and 5 non-malignant bone samples, was gained from Gene Expression Omnibus (GEO) database. The differentially expressed genes (DEGs) were picked out by GEO2R online R soft tool. Furthermore, the protein-protein interaction (PPI) network between the DEGs was molded utilizing STRING online software. Afterward, PPI network of DEGs was constructed. Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis of DEGs were carried out on DAVID online tool and visualized via cytoscape software. Subsequently, module analysis of PPI was performed by using MCODE app. What’s more, prognosis-related genes were screened by using online databases including GEPIA, UALCAN and cBioPortal databases. Results: Totally, 671 DEGs were picked out, including 501 up-regulated genes and 170 down-regulated genes. Moreover, 22 hub genes were identified to be significantly expressed in PPI network (16 up-regulated and 6 down-regulated). We found that spliceosome signaling pathway may provide a potential target in OS. Furthermore, on the basis of common crucial pathway, PRPF38A and SNRPC were closely associated with spliceosome. Conclusion: This study showed that SNRPC and PRPF38A are potential biomarkers candidates for osteosarcoma.

Personalized Driver Gene Prediction Using Graph Convolutional Networks with Conditional Random Fields

“…Table S1: The table shows the new biomarker genes identified in the two datasets and the corresponding descriptions. References [ 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 , 61 , 62 , 63 , 64 , 65 , 66 , 67 , 68 , 69 , 70 , 71 , 72 , 73 , 74 , 75 , 76 , 77 , 78 , 79 , 80 , 81 , 82 , 83 , 84 , 85 , 86 , 87 , 88 , 89 , 90 , 91 , 92 , 93 , 94 , 95 ] are cited in the Supplementary Materials.…”